Evidence map›Paper›PMID 24811749›Full record

ArticleThe EMBO journal2014

Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates.

Henrike C Besche, Zhe Sha, Nikolay V Kukushkin, Andreas Peth, Eva-Maria Hock, Woong Kim, Steven Gygi, Juan A Gutierrez, Hua Liao, Lawrence Dick and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 175 citations in OpenAlex.

  1. Mapping the proteome landscape inPlant signaling & behavior · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Covalent inhibition ofiScience · 2025
    Article
  10. Article
  11. Review
  12. Temporal control of acute protein aggregate turnover by UBE3C and NRF1-dependent proteasomal pathways.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. DNA damage-induced proteasome phosphorylation controls substrate recognition and facilitates DNA repair.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Henrike C BescheHarvard Medical School, Boston, MA, USA.
Zhe ShaHarvard Medical School, Boston, MA, USA.
Nikolay V KukushkinHarvard Medical School, Boston, MA, USA.
Andreas PethHarvard Medical School, Boston, MA, USA.
Eva-Maria HockHarvard Medical School, Boston, MA, USA.
Woong KimHarvard Medical School, Boston, MA, USA.
Steven GygiHarvard Medical School, Boston, MA, USA.
Juan A GutierrezMillennium Pharmaceuticals Inc., Cambridge, MA, USA.
Hua LiaoMillennium Pharmaceuticals Inc., Cambridge, MA, USA.
Lawrence DickMillennium Pharmaceuticals Inc., Cambridge, MA, USA.
Alfred L GoldbergHarvard Medical School, Boston, MA, USA alfred_goldberg@hms.harvard.edu.
Harvard University · USMillennium Engineering and Integration (United States) · US

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
MOLECULAR CHAPERONES AND PROTEIN DEGRADATIONR01GM051923 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GOLDBERG, ALFRED L · 1995 to 2020
$10.1M
NIGMS NIH HHS 5R01 GM51923NIGMS NIH HHS R01 GM051923NIGMS NIH HHS R01 GM067945
6 · The paper itself

Abstract

Degradation rates of most proteins in eukaryotic cells are determined by their rates of ubiquitination. However, possible regulation of the proteasome's capacity to degrade ubiquitinated proteins has received little attention, although proteasome inhibitors are widely used in research and cancer treatment. We show here that mammalian 26S proteasomes have five associated ubiquitin ligases and that multiple proteasome subunits are ubiquitinated in cells, especially the ubiquitin receptor subunit, Rpn13. When proteolysis is even partially inhibited in cells or purified 26S proteasomes with various inhibitors, Rpn13 becomes extensively and selectively poly-ubiquitinated by the proteasome-associated ubiquitin ligase, Ube3c/Hul5. This modification also occurs in cells during heat-shock or arsenite treatment, when poly-ubiquitinated proteins accumulate. Rpn13 ubiquitination strongly decreases the proteasome's ability to bind and degrade ubiquitin-conjugated proteins, but not its activity against peptide substrates. This autoinhibitory mechanism presumably evolved to prevent binding of ubiquitin conjugates to defective or stalled proteasomes, but this modification may also be useful as a biomarker indicating the presence of proteotoxic stress and reduced proteasomal capacity in cells or patients.

Indexed as

UbiquitinationBlotting, WesternCell LineHumansIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsProteasome Endopeptidase ComplexADRM1 protein, humanATP dependent 26S proteaseIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsProteasome Endopeptidase Complex26S proteasomesproteasome inhibitorsproteasome regulationUbe3c/Hul5ubiquitination

Identifiers

PMID24811749
PMCPMC4193922
OpenAlexW2036380827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.